Based on the Sartorius Aktiengesellschaft stock forecast from 0 analysts, the average analyst target price for Sartorius Aktiengesellschaft is not available over the next 12 months. Sartorius Aktiengesellschaft’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sartorius Aktiengesellschaft is Bearish, which is based on 4 positive signals and 11 negative signals. At the last closing, Sartorius Aktiengesellschaft’s stock price was USD 259.02. Sartorius Aktiengesellschaft’s stock price has changed by +0.86% over the past week, +30.26% over the past month and -10.48% over the last year.
No recent analyst target price found for Sartorius Aktiengesellschaft
No recent average analyst rating found for Sartorius Aktiengesellschaft
Company Overview Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, and support and services; live-cell imaging and analysis software; contract manufacturing and integration; OEM membranes and devices, weigh cells, and data analytics; connectivity, and pipetting and dispensing products; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and surface plasmon resonance and process filtration products. The company offers water purification systems; lab data and fleet management software; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, weights and weight sets, paint mixing solutions, and weighing accessories; and bioprocess consulting and engineering, biologics testing, cell culture media, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany. Read Less
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture s...Read More
Frequently Asked Questions About Sartorius Aktiengesellschaft (SUVPF) Stock
Stock Target Advisor's fundamental analysis for Sartorius Aktiengesellschaft's stock is Bearish.
SUVPF stock's dividend yield is 0.40%.
Our analysis grades SUVPF stock's dividend yield at F. This means that SUVPF stock's dividend yield is above 19% of the stocks in the Medical Instruments & Supplies sector in the OTC exchange.
Based on this SUVPF may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on SUVPF's stock to indicate what its average analyst target is.
SUVPF stock's Price/Earning ratio is 126.66.
Our analysis grades SUVPF stock's Price / Earning ratio at F. This means that SUVPF stock's Price/Earning ratio is above 82% of the stocks in the Medical Instruments & Supplies sector in the OTC exchange.
Based on this SUVPF may be a overvalued for its sector.
The last closing price of SUVPF's stock was USD 259.02.
The most recent market capitalization for SUVPF is USD 16.40B.
Unfortunately we do not have enough analyst data on SUVPF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sartorius Aktiengesellschaft's stock.
As per our most recent records Sartorius Aktiengesellschaft has 13,573 Employees.
Sartorius Aktiengesellschaft's registered address is Otto-Brenner-Strasse 20, Göttingen, Germany, 37079.
You can get more information about it from Sartorius Aktiengesellschaft's website at https://www.sartorius.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Sartorius Aktiengesellschaft (SUVPF) Stock
Stock Target Advisor's fundamental analysis for Sartorius Aktiengesellschaft's stock is Bearish.
SUVPF stock's dividend yield is 0.40%.
Our analysis grades SUVPF stock's dividend yield at F. This means that SUVPF stock's dividend yield is above 19% of the stocks in the Medical Instruments & Supplies sector in the OTC exchange.
Based on this SUVPF may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on SUVPF's stock to indicate what its average analyst target is.
SUVPF stock's Price/Earning ratio is 126.66.
Our analysis grades SUVPF stock's Price / Earning ratio at F. This means that SUVPF stock's Price/Earning ratio is above 82% of the stocks in the Medical Instruments & Supplies sector in the OTC exchange.
Based on this SUVPF may be a overvalued for its sector.
The last closing price of SUVPF's stock was USD 259.02.
The most recent market capitalization for SUVPF is USD 16.40B.
Unfortunately we do not have enough analyst data on SUVPF's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sartorius Aktiengesellschaft's stock.
As per our most recent records Sartorius Aktiengesellschaft has 13,573 Employees.
Sartorius Aktiengesellschaft's registered address is Otto-Brenner-Strasse 20, Göttingen, Germany, 37079.
You can get more information about it from Sartorius Aktiengesellschaft's website at https://www.sartorius.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SUVPF !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
